108 oral DOSE TO MEDIUM AND WATER IN LOW ENERGY BRACHYTHERAPY
- 作者G. Landry; J.P. Pignol; L. Beaulieu; F. Verhaegen; B. Reniers
- 卷第99卷
- 文件大小86.02KB
- 发表时间2011
- DOI10.1016/s0167-8140(11)70231-6
Radiotherapy-Related Lung Fibrosis Enhanced by TamoxifenBentzen, S. M.; Skoczylas, J. Z.; Overgaard, M.; Overgaard, J. · JNCI Journal of the National Cancer Institute · 1996
Hyperthermic Tumour-Cell Devitalization in VivoOvergaard, K.; Overgaard, J. · Acta Oncologica · 1977
Clinical radiobiology of malignant melanomaBentzen, S.M.; Overgaard, J.; Thames, H.D.; Overgaard, M.; Hansen, P.Vejby; von der Maase, H.; Meder, J. · 1989
26 Single nucleotide polymorphisms in candidate genes correlate with clinical normal tissue radiosensitivityC.N. Andreassen; J. Alsner; M. Overgaard; J. Overgaard · 2003
ATM sequence variants and adverse radiotherapy response in breast cancer patientsB.S. Rosenstein; C.N. Andreassen; J. Alsner; M. Overgaard; J.A. Cesaretti; D.A. Atencio; S. Green; S.C. Formenti; R.G. Stock; J. Overgaard · 2004
822 Assessment of human fibroblast radiosensitivity by the micronucleus and colony-forming assayJ. Johansen; S.M. Bentzen; J. Overgaard; B. Stausbel; M. Overgaard; C. Fuhrmann; C. Streffer · 1995
FACTORS ASSOCIATED WITH ACUTE AND LATE DYSPHAGIA IN THE DAHANCA 6 & 7 TRIALH.R. Mortensen; K. Jensen; J. Overgaard; L. Specht; M. Overgaard; J. Johansen; J.F. Evensen; E. Andersen; L.J. Andersen; H.S. Hansen; C. Grau · 2011
A phase I clinical study of nimorazole as a hypoxic radiosensitizerA.R. Timothy; J. Overgaard; M. Overgaard · 1984